A Review of the Effects of Moderate Alcohol Intake on Psychiatric and Sleep Disorders

Castañeda, Ricardo; Sussman, Norman; Levy, Robert; O'Malley, Mary; Westreich, Laurence M.

doi:10.1007/0-306-47148-5_9

Cited by 50 publications

(57 citation statements)

References 136 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is also beyond the scope of this report to provide a critical review of pharmacological research in this area, much of which involves experimental studies of humans and laboratory animals. However, even moderate amounts of alcohol are not recommended for patients with existing mood and anxiety disorders (see Section 10.2) because of the potential for adverse drug-interactions, as well as the likelihood of worsening of symptoms (Castaneda et al, 1996;Castaneda et al, 1998).…”

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

“…Because of the significance of expectancy effects, experimental studies able to control for these effects provide more relevant data than non-experimental studies based on self-reports. Reviews of the experimental studies of stress-reduction in humans, however, have concluded that this evidence is highly inconsistent (Pohorecky, 1991;Eckardt et al, 1998;Castaneda et al, 1998). Whether physiologic measures of reduced stress response are found in the predicted direction varies according to the type of physiologic response measured, the stressful stimulus used, the dose used, and whether the blood alcohol level was rising or falling (Stritzke et al, 1996;Wilson et al, 1982;Eckardt et al, 1998).…”

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

“…One frequently cited paper reported that some subjects have exhibited increased anxiety as measured by physiologic changes, while perceived anxiety has been reduced (Pohorecky, 1991). Withdrawal from alcohol, in humans, has also been shown to result in depressive symptoms and excitability (Castaneda et al, 1996). Sufficient evidence exists to show that moderate alcohol use is associated with perceived reduction of stress in individuals with positive expectancies about its stressreducing properties.…”

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

“…At this time, it would also be irresponsible to advise alcohol use for stress-reduction, given the possible link between this strategy and addiction. Further, the use of alcohol for this purpose may lead to adverse effects such as worsening mood and anxiety problems and aggravate sleepdisorders (Castaneda et al, 1998) Another benefit popularly attributed to alcohol is as a sleep aid (for review, see (Castaneda et al, 1998). Although moderate alcohol may induce sleep, it also leads to increased wakefulness and arousal, several hours later and so is well-documented as having aggravating effect is sleep disorders.…”

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

“…As already stated, even moderate amounts of alcohol are not recommended for anyone with existing mood or anxiety disorders because of the potential for adverse druginteractions, as well as the likelihood of worsening of symptoms (Castaneda et al, 1996;Castaneda et al, 1998). Individuals with specific conditions, such as bipolar affective disorders, may be at a significantly increased risk of alcohol dependence, and even moderate drinking may worsen the course of the condition (Castaneda et al, 1998).…”

Section: People Experiencing Problems With Mood Anxiety and Sleep DImentioning

confidence: 99%

See 4 more Smart Citations

Evidence Regarding the Level of Alcohol Consumption Considered to be Low-Risk for Men and Women

Single¹,

Ashley²,

Bondy³

et al. 2000

PsycEXTRA Dataset

View full text Add to dashboard Cite

The strategic intent of the NHMRC is to work with others for the health of all Australians, by promoting informed debate on ethics and policy, providing knowledge based advice, fostering a high quality and internationally recognised research base, and applying research rigour to health issues. NHMRC documents are prepared by panels of experts drawn from appropriate Australian academic, professional, community and government organisations. NHMRC is grateful to these people for the excellent work they do on its behalf. This work is usually performed on an honorary basis and in addition to their usual work commitments.

show abstract

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

Section: Stress Reduction and Mood Elevationmentioning

confidence: 99%

Section: People Experiencing Problems With Mood Anxiety and Sleep DImentioning

confidence: 99%

See 3 more Smart Citations

Evidence Regarding the Level of Alcohol Consumption Considered to be Low-Risk for Men and Women

Single¹,

Ashley²,

Bondy³

et al. 2000

PsycEXTRA Dataset

View full text Add to dashboard Cite

show abstract

Treatment-refractory depression: Definitions and characteristics

1997

View full text Add to dashboard Cite

Forty to 50% of depressed patients who are initially prescribed antidepressant medications or administered electroconvulsive therapy do not experience a timely remission. This group typifies treatment‐refractory depression (TRD), defined as a failure to demonstrate an “adequate” response to an “adequate” treatment trial (i.e., sufficient intensity of treatment for sufficient duration). The approach to the patient with TRD must be methodical. The clinician should examine potential factors contributing to apparent non‐response: trial adequacy, compliance, differential diagnosis, and treatable comorbid conditions. After addressing these variables, a patient who does not demonstrate a remission may be considered treatment resistant (relative or absolute). Although many of these patients will respond to a subsequent treatment regimen, there are no (or only nominally useful) predictors for the initial selection of that “subsequent” antidepressant treatment. Hence, the initial treatment is typically chosen on the basis of safety and convenience, not differential efficacy. The search for the clinical and biological correlates of long‐term or acute outcome presents a major nosologic conundrum: Who will respond to treatment? Which treatment? In this manner, TRD challenges the prognostic utility of our current phenomenologic‐based diagnostic system. Depression and Anxiety 5:154–164, 1997. © 1997 Wiley‐Liss, Inc.

show abstract

Incidence of cancer and antidepressant medication: Record linkage study

Haukka

Sankila

Klaukka

et al. 2009

Intl Journal of Cancer

View full text Add to dashboard Cite

The consumption of antidepressants, especially selective serotonine reuptake inhibitors (SSRI) has been increasing. Because a large fraction of the population is exposed, even a small excess of risk with respect to cancer should be considered. We carried out a record linkage study in Finland utilizing nationwide databases of reimbursed medication and cancer. The study population included all antidepressant drug (AD) users in Finland who had purchased at least 1 prescription between 1998 and 2005, and who had no cancer diagnosis at the date of first purchase. A control population without AD usage (matched by age and sex) was also included. Data consisted of 418,588 pairs of individuals that cumulated 3.3 million person-years with an average of 4.0 years of follow-up. 19,365 cancer cases were observed. The most frequent cancers were breast, prostate, lung, colon, and brain cancer. In general, only few associations between the utilization of AD and cancer could be detected. Over four years exposure to AD showed a weak association with increased colon and breast cancer incidence, which could have been caused by bias. As conclusion, no clear evidence of neither beneficial nor harmful association between usage of antidepressant and cancer was found.

show abstract

A Review of the Effects of Moderate Alcohol Intake on Psychiatric and Sleep Disorders

Cited by 50 publications

References 136 publications

Evidence Regarding the Level of Alcohol Consumption Considered to be Low-Risk for Men and Women

Evidence Regarding the Level of Alcohol Consumption Considered to be Low-Risk for Men and Women

Treatment-refractory depression: Definitions and characteristics

Incidence of cancer and antidepressant medication: Record linkage study

Contact Info

Product

Resources

About